A. Leigh Corbett

Staff Reporter

Email: corbett@ocbj.com
Phone: 949-833-8373 Extension: 254

Recent Stories

UCI Health Names CEO

Promotes COO Lefteris To Top Post

UCI Health said Chad Lefteris is taking on the role of chief executive effective immediately. His new appointment will allow his supervision to cover UCI’s academic medical center and all the clinical and patient operations of Orange County’s largest hospital.

CalOptima Names Interim Chief

Board member Sanchez begins April 6

Tease photo

Midday Stock Roundup

Ensign Group, Urovant rise

Tease photo

UCI Health Promotes Lefteris to CEO

Former COO replaces Gannotta

Tease photo

Dendreon Maintains Production

Cancer drug maker works, talks

Tease photo

Edwards Pauses Some New Enrollments

Manufacturing continues

Tease photo

Irvine Scientific Parent’s Drug Praised

Fujifilm’s Drug Tests Well on Coronavirus

The parent company of Santa Ana-based Fujifilm Irvine Scientific may have a treatment for the coronavirus.

Neurolens Raises $23.8M, SEC Filings Show

Touts Product To Reduce Eyestrain

Costa Mesa-based Neurolens Inc., which is trying to reduce the problem of eyestrain from viewing digital devices, disclosed it has raised $23.8 million, according to a March 12 filing with the Securities and Exchange Commission.

Glaukos Coronavirus Moves

Smaller shifts, $183M cash

Tease photo

Midday Stock Roundup

Indexes rise despite jobless claims jump

Tease photo

Healthpeak Coronavirus Plan

Construction, disposition delays; $3.3B liquidity

Tease photo

Healthcare Workers Seek ‘Mercedes of Masks’

Irvine Maker’s MaxAir System in High Demand

Irvine-based Bio-Medical Devices International Inc. is seeing increasing demand for its purifying respirator MaxAir Systems to fight the coronavirus.

Octane Resets Two Meetings

Forums moved to late summer, early fall

Tease photo

Midday Stock Roundup

FivePoint, CareTrust, NextGen jump big

Tease photo

NeuroVasc’s $34M Funding China-Backed

Clot-Retrieval Device Moves to Trials

Irvine-based NeuroVasc Technologies Inc. raised $34 million from China-based Wego Group to support the company’s global clinical trial program for ischemic stroke.

NowRX Raises $10M; Same-Day Delivery

New Irvine Office Runs 4,500 SF

NowRX raised over $10 million last month from small investors using SeedInvest to help with its expansion in Southern California, including its Irvine office.

Viseon Secures $18M Series B For Commercialization Efforts

Cites Positive Response To New Spine TV Device

Irvine-based Viseon Inc., an orthopedic spine technology company, has secured $18 million in Series B funding to bring its product into full commercialization.

MRI Interventions Changes Name

Says ClearPoint Neuro Reflects Evolution

Irvine-based ClearPoint Neuro Inc. has changed its name from MRI Interventions and has a Nasdaq ticker symbol “CLPT.”

Modulim Seeks $15M Series C

Says Ulcer Detector Ready for Market

Irvine-based Modulim says it is on the cusp of changing the lives of diabetic patients.

Device Maker Gets $34M

China money for trials, development

Tease photo

Skincare Firm Aivita Raises $12.5M

Anti-Aging Product Big Hit in Japan

Irvine-based Aivita Biomedical Inc., a biotech company specializing in stem cell applications for various uses, closed a Series B2 round of funding for $12.5 million.

ImmunogenX Begins Celiac Disease Trial

Mayo Clinic, Columbia University to Study

Newport Beach-based ImmunogenX LLC, an early-stage drug developer, earlier this month said it began patient enrollment for its Phase 2b clinical trial for its treatment of celiac disease, an incurable digestive ailment that destroys the lining of the intestines.

Cancer Centers Take Center Stage

OC’s Growing Hub for Cancer Care, Research, Funding

$1 billion is just the beginning.

Tease photo

Midday Stock Roundup

Kaiser Aluminum Corporation surged 7.2% at midday trading

Tease photo

Invisible Braces Firm Names CFO

Cousins a Vet Of IPOs, M&As

Irvine-based Inbrace, a maker of “invisible braces” which said it had record sales and raised $45 million in Series C funding, has named Kevin Cousins chief financial officer.

Mission Hospital Touts OncoCyte Partnership

DetermaRx Test Used For Lung Cancer Treatment

The recently opened Judi and Bill Leonard Institute for Cancer Prevention, Treatment and Wellness at Mission Hospital in Mission Viejo has announced a partnership with new Orange County public company OncoCyte Corp. to use its product DetermaRx.

Local Medtech Scene Showcasing Newest

Firms Seeking Support At Emerging Summit

Sometimes, you can’t tell the medtech players without a scorecard.

Medtech Rising

A number of teams, most from out of the area, are sending players to Dana Point this week to talk medtech.

Hospitals: Some Changes in Revenue, Fewer in Ranks

31 Facilities; $9.1 Billion; A Few Double-Digit Swings

To say hospitals are stable is a good thing, especially for people spending time there.

Midday Stock Roundup

First American tops average analyst estimates in quarter

Tease photo

BioCorRx Gets Fed Funding to Treat Opiods

CEO Says Gov’t Backing Validates Progress

Anaheim-based BioCorRx Inc., a thinly traded small-cap stock, claims it’s developing a novel approach to treating opioid addiction.

Glidewell Celebrates; Campus Keeps Expanding

OC’s No. 3 Device Maker by Size

Irvine-based Glidewell Dental Laboratories celebrated its 50th anniversary mid-January “with a relatively humble employee celebration,” according to press release.

Cryoport HQ Shifts To Nashville Area

HEALTHCARE: CEO moves, Irvine ops remain

Cryoport Inc., the fast-growing provider of cold-chain logistics services for the biopharmaceutical industry, is the latest local company to move its headquarters to the area around Nashville, Tenn.

Midday Stock Roundup

Ensign beats; ICU up

Tease photo

MemorialCare Opens South County Center

Rancho Mission Viejo Health Site Runs 26K SF

It’s not just housing that’s growing in the South County master-planned community of Rancho Mission Viejo.

JenaValve Earns ‘Breakthrough’ Device Nod from FDA

Can Move Quickly Into Clinical Trials

Irvine-based JenaValve Technology Inc. crossed a major hurdle when its transcatheter aortic valve replacement (TAVR) device for severe aortic regurgitation (AR) and AR-dominant mixed aortic valve disease was declared a “breakthrough device” by the Food and Drug Administration.

Midday Stock Roundup

Staar Surgical down on coronavirus concerns

Tease photo

Fast Funds, Fast-Grower: $85M for Sonendo

MEDTECH: Root canal alternative eyes expansion

From the guys who brought OC Glaukos

Tease photo

Avid Names New Commercial Officer

Analysts Expect 25% Sales Growth in 2020

Tustin-based contract drugmaker Avid Bioservices Inc. named Timothy Compton chief commercial officer this month.

Masimo Pays $47M For NantHealth Unit

Soon-Shiong Praises Co. As ‘Best’ of Type

Masimo Corp. (Nasdaq: MASI), the Irvine-based maker of noninvasive medical monitoring equipment, will purchase the assets of Culver City-based NantHealth’s Connected Care business for $47.3 million cash.

Avid Names Chief Commercial Officer

Compton joins amid analyst-expected growth

Tease photo

Midday Stock Roundup

Lantronix up on hiring of ex-Microsemi exec

Tease photo

City of Hope Steps Up

NB debut presages Irvine, OC presence

Tease photo

UCI Brings Top Minds Together for Brain Research

EDUCATION: New initiative emphasizes multi-disciplines

University of California-Irvine in 1964 was the first department of neuroscience in the U.S., which meant it was first to be studying the brain in an academic setting.

Tease photo

Viseon’s Spine Imaging Product Moves Ahead

FDA Nod; Ex-Parent Sells for Up to $100M+

Irvine-based medical device maker Viseon Inc. is getting closer to commercializing its first product, which helps doctors better visualize the spine during surgery to that part of the body.

Midday Stock Roundup

FivePoint up 31% this week (keep reading)

Tease photo

Urovant Gets Japan Investor Boost

$300M Loan; FDA Progress for 2020

Urovant Sciences Ltd. (Nasdaq: UROV), which is developing medications to treat urologic issues, is starting the year with a new main investor from Japan, a $300 million loan, and progress in getting its core drug, vibegron, to market in the U.S.

Midday Stock Roundup

Axonics Modulation Technologies Inc. leaps 25% (keep reading)

Tease photo

AbbVie Names Strom to Head Allergan Unit

“The future has never been brighter"

Tease photo

CathWorks Gets Japanese Approval

First Such Artery Imaging Device for Japan

Aliso Viejo-based CathWorks, a medical device maker that provides 3D imaging of the coronary artery branch, announced in December the approval of its FFRangio system by Japan’s Ministry of Health, Labour and Welfare.